ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF FENOFIBRATE IN BULK AND FORMULATIONS VIA UV SPECTROPHOTOMETRY

GITA CHAURASIA; AJANTA TOTRE; SWATI DESHMUKH

doi:10.22159/ijpps.2025v17i12.56405

Authors

GITA CHAURASIA Department of Pharmaceutics, Siddhant College of Pharmacy, Sudumbare-412109, Pune, Maharashtra, India https://orcid.org/0009-0002-3375-8128
AJANTA TOTRE Department of Pharmaceutics, Siddhant College of Pharmacy, Sudumbare-412109, Pune, Maharashtra, India https://orcid.org/0009-0001-7498-8723
SWATI DESHMUKH Department of Pharmaceutics, Siddhant College of Pharmacy, Sudumbare-412109, Pune, Maharashtra, India

DOI:

https://doi.org/10.22159/ijpps.2025v17i12.56405

Keywords:

Fenofibrate, Estimation of fenofibrate, UV methods, Fenofibrate analysis, Anti-hyperlipidaemic drug, Lipoprotein lipase activators

Abstract

Objective: The aim of the present work was developing the Ultra-violate (UV) spectroscopic analytical method for analysis of Fenofibrate in bulk and formulations. The drug is used for the treatment of primarily hypercholesterolemia and mixed dyslipidemia.

Methods: The precise, convenient, simple, sensible and reproducible UV methods were developed, in solvents includes Methanol pure (A), Pure Polyethylene glycol (PEG)-400 (B), Ethanol: Propylene glycol (1:9) solution (EPG)-(C). Each were scanned in range of200-400 nm at concentration of 10µg/ml. The linearity with high sensitivity was obtained in UV spectrum, in therangefrom5-55μg/ml in solvents A, B and C, via Double beam UV-Visible Spectrophotometer. Validation was done as per ICH Q2B guideline parameters (Range, Linearity, Robustness, Precision, Ruggedness, Accuracy, Limit of detection (LOD) and Limit of quantification (LOQ), by using predefined calibration standards for the developed methods. Marketed formulation Lipicard-160 tablets I. P. was used for method validation in each solvent A, B and C.

Results: The absorption maxima was observed in the solvents A, Band C, at 287.0 nm; 288.0 nm and286.0 nm, and the percentage average drug recovery was found to be 99.87; 99.74 and 98.76 respectively (n=6).

Conclusion: The proposed method was successfully developed in chosen solvents and validated for the determination of Fenofibrate in bulk and formulations as per ICH Q2B parameters.

Downloads

Download data is not yet available.

References

1. Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 1998 Nov 10;98(19):2088-93. doi: 10.1161/01.CIR.98.19.2088, PMID 9808609.

2. Kumar SA, Debnath A, Rao JV, Sankar DG. Development and validation of a sensitive RP-HPLC method for simultaneous estimation of rosuvastatin and fenofibrate in tablet dosage form by using PDA detector in gradient mode. Res J Pharm Technol. 2016;9(5):549. doi: 10.5958/0974-360x.2016.00104.9.

3. Sukumar V, Chinnusamy S, Chanduluru HK, Rathinam S. Method development and validation of atorvastatin ezetimibe and fenofibrate using RP-HPLC along with their forced degradation studies and greenness profiling. Green Chem Lett Rev. 2023 Jan 2;16(1):2198651. doi: 10.1080/17518253.2023.2198651.

4. Kalyankar GG, Ghariya VV, Bodiwala KB, Lodha SR, Joshi SV. Development and validation of HPTLC method for simultaneous estimation of fenofibrate and rosuvastatin in tablet dosage form. J Pharm Appl Sci. 2016;3(1):1-7.

5. Gupta KR, Sonali S, Askarkar P, Rathod PR, Wadodkar SG. Validated spectrophotometric determination of fenofibrate in formulation. Pharm Sin. 2010;1(1):173-8.

6. Mathrusri Annapurna M, Tejasri P, Narendra A. New spectrophotometric method for the estimation of fenofibrate. Res J Pharm Technol. 2024;17(6):2753-6. doi: 10.52711/0974-360X.2024.00431.

7. Gaikwad PV, Sawant SD, Ghante MR, Munot NM. Three simple spectrometric methods for fenofibrate in tablet form. J Pharm Res. 2011;4(6):1741-2.

8. Jadhav V, Raut C, Dhabale PN. UV-spectrophotometry estimation of fenofibrate in tablet dosage form. Asian J Res Chem. 2010;3(2):326-8.doi: 10.5958/0974-4150.

9. Noor A, Babu PS, Aravind P. Formulation development and in vitro evaluation of immediate release fenofibrate pellets. Asian J Complement Altern Med. 2014;2(3):1-6.

10. Nikalje AG, Choudhari VP. Validated TLC method for simultaneous quantitation of atorvastatin ezetimibe and fenofibrate in bulk drug and formulations. Acta Chromatographica. 2011;23(2):267-80. doi: 10.1556/achrom.23.2011.2.6.

11. Diogo HP, Viciosa MT, Ramos JJ. Differential scanning calorimetry and thermally stimulated depolarization currents study on the molecular dynamics in amorphous fenofibrate. Thermochim Acta. 2016;623:29-35. doi: 10.1016/j.tca.2015.11.012.

12. Shihabi ZK. Fenofibrate and fenofibric acid analysis by capillary electrophoresis. Electrophoresis. 2004;25(10-11):1648-51. doi: 10.1002/elps.200305849, PMID 15188253.

13. Salamaa FM, Nassar MW, El Din MM, Attia KA, Kaddah MY. Determination of fenofibrate and the degradation product using simultaneous UV-derivative spectrometric method and HPLC. Am J Anal Chem. 2011;2(3):332-43. doi: 10.4236/ajac.2011.23041.

14. Lacroix PM, Dawson BA, Sears RW, Black DB, Cyr TD, Ethier JC. Fenofibrate raw materials: HPLC methods for assay and purity and an NMR method for purity. J Pharm Biomed Anal. 1998;18(3):383-402. doi: 10.1016/S0731-7085(98)00051-x, PMID 10096833.

15. Dutt B, Choudhary M, Budhwar V. Preparation characterization and evaluation of fenofibrate: benzoic acid cocrystals with enhanced pharmaceutical properties. Futur J Pharm Sci. 2021;7(1):170-6. doi: 10.1186/s43094-021-00320-5.

16. International Conference on Harmonisation (ICH). ICH Q2(R1): Validation of analytical procedures-text and methodology. Geneva: ICH; 2005. p. 10–62.

17. Jyothi BJ, Kavya RV. Ultraviolet spectrophotometric method development for estimation of new antiviral repurposing drug favipiravir. Asian J Pharm Clin Res. 2021;14(7):67-9. doi: 10.22159/ajpcr.2021.v14i7.41966.

18. Chauhan I, Singh LU. Development and validation of a simple and cost-effective UV spectrophotometric method for quantifying linezolid. Int J App Pharm. 2024;16(3):211-6. doi: 10.22159/ijap.2024v16i3.50556.

19. Funde A, Kokat J. A validated stability indicating UV-spectrophotometric simultaneous estimation of rosuvastatin calcium and fenofibrate in bulk and pharmaceutical formulation. Int J Chem Res. 2021;5(1):1-8. doi: 10.22159/ijcr.2021v5i1.144.

20. Kutty SV, Eapen SC, Shameer M, P FP. Validated UV-visible spectrophotometric method for the estimation of fenofibrate in pure and pharmaceutical formulation using MBTH reagent. Int J Pharm Sci Drug Res. 2012;4(1):74-6. doi: 10.25004/IJPSDR.2012.040113.

21. Raosaheb GG, Garje MA, Dode AB, Dhaygude AM, Wagh DV, Fartade SJ. Validated spectrophotometric method for simultaneous estimation of fenofibrate and atorvastatin in synthetic mixture and in bulk tablet dosage form. World J Pharm Med Res. 2020;6(7):170-6.